Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.

Details

Language :

English

ISSN :

0732183X

Volume :

26

Issue :

4

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105862171

Full Text :

https://doi.org/10.1200/JCO.2007.11.0304